Andres Orjuela, MD
Otolaryngology · Miami, FLNPI 1588687933
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Optinose US, Inc. at 43.5% of the total. Reporting peaked in 2021 at $81 and has fallen 66.4% since, to $27 in 2022. That places this record below the midpoint for otolaryngology clinicians in FL, where the typical reported total is $1,552.
Across 13 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$109
- Stryker$48
- Intersect ENT, Inc.$41
- Sanofi$27
- Smith+Nephew$15
- Integra Lifesciences Corporation$11
Across 11 payments — averaging $2711.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Roche Products Limited$30K
What the payments were for
- Food & beverage$252100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 7 | $109 |
| Stryker | 2 | $48 |
| Intersect ENT, Inc. | 1 | $41 |
| Sanofi | 1 | $27 |
| Smith+Nephew | 1 | $15 |
| Integra Lifesciences Corporation | 1 | $11 |
How this compares
$252 in reported general payments places this provider in the 20th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 52 | $106,239 |
| Ipratropium Bromide | 227 | $4,930 |
| Fluocinolone Acetonide Oil | 107 | $1,789 |
| Azelastine Hcl | 105 | $889 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $833 |
| Triamcinolone Acetonide | 32 | $604 |
| Fluticasone Propionate | 132 | $475 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 56 | $308 |
| Ciprofloxacin Hcl | 31 | $191 |
| Ofloxacin | 37 | $174 |
| Famotidine | 102 | $160 |
| Mupirocin | 70 | $158 |
| Nystatin | 15 | $137 |
| Clindamycin Hcl | 12 | $54 |
| Prednisone | 88 | $54 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Miami
- Maria SuurnaMiami$189K
- Agustin ArrietaMiami$95K
- Francisco PernasMiami$70K
- Adrien EshraghiMiami$41K
- Michael HofferMiami$24K
- Corinna LevineMiami$16K
- Jason LeibowitzMiami$13K
- Donald WeedMiami$8K
- Cecelia DamaskOrlando$707K
- Ralph TufanoSarasota$469K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.